OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY IN CANCER PATIENTS
Clinical trials for OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY IN CANCER PATIENTS explained in plain language.
Never miss a new study
Get alerted when new OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY IN CANCER PATIENTS trials appear
Sign up with your email to follow new studies for OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY IN CANCER PATIENTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Exercise may ease Chemo's nerve pain, new study hopes to prove
Symptom relief Not yet recruitingThis study looks at whether exercise can lessen nerve damage caused by certain chemotherapy drugs. About 140 people with colorectal or gynecologic cancer will either exercise or receive usual care. Researchers will measure nerve function, blood markers, and quality of life to see…
Matched conditions: OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY IN CANCER PATIENTS
Phase: NA • Sponsor: National Cancer Center, Korea • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
Blood test may predict chemo nerve damage before it starts
Knowledge-focused Not yet recruitingThis study aims to find blood markers that can predict which cancer patients will develop chronic nerve pain from chemotherapy. Researchers will collect blood samples and perform neurological exams on 192 patients over 6 months. The goal is to use this information to personalize …
Matched conditions: OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY IN CANCER PATIENTS
Sponsor: Centre Hospitalier de Bligny • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC